₹247.45
▼ -4.46 -1.77%
18 Jul 2026
NSE Listed · Pharmaceuticals
Indoco Remedies Ltd. (INDOCO)
Volume: 4,764Avg Vol 1W: 63,737Avg Vol 1M: 1,02,03952W Range:₹162.19₹349.8
Key Ratios
Checked just nowMarket Cap₹2,284 Cr
Current Price₹247.45
Previous Close₹251.91
High / Low (52w)₹349.8 / ₹162.19
Volume4,764
Avg Vol (1W)63,737
Avg Vol (1M)1,02,039
Stock P/E—
Book Value₹101.76
Dividend Yield8%
ROE-10.13%
ROA-380.56%
Revenue (TTM)—
Revenue Growth-8.38%
Profit Margin-5.31%
Total Debt₹533 Cr
Shares Outstanding9 Cr
Face Value₹2
EPS (TTM)₹0
P/B2.43
Debt / Equity0.78
50 DMA₹242.24
200 DMA₹214.17
Day change-1.77%
Price Chart
₹247.45▼ 2.88% · 1Y
2025-11-252026-07-17
20-day avg volume: 1.1L shares
Pros
- Pays a dividend yield of 8.0%.
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹431 Cr | ₹433 Cr | ₹411 Cr | ₹390 Cr | ₹440 Cr | ₹485 Cr | ₹445 Cr | ₹476 Cr |
| EBITDA | ₹21 Cr | ₹13 Cr | ₹-16 Cr | ₹-28 Cr | ₹-11 Cr | ₹12 Cr | ₹0 Cr | ₹17 Cr |
| Net Profit | ₹3 Cr | ₹-10 Cr | ₹-26 Cr | ₹-40 Cr | ₹-36 Cr | ₹-8 Cr | ₹-30 Cr | ₹-22 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,047 Cr | ₹975 Cr | ₹1,109 Cr | ₹1,245 Cr | ₹1,543 Cr | ₹1,671 Cr | ₹1,827 Cr | ₹1,670 Cr |
| EBITDA | ₹72 Cr | ₹11 Cr | ₹55 Cr | ₹154 Cr | ₹251 Cr | ₹218 Cr | ₹162 Cr | ₹-9 Cr |
| Net Profit | ₹41 Cr | ₹-3 Cr | ₹24 Cr | ₹93 Cr | ₹155 Cr | ₹142 Cr | ₹98 Cr | ₹-74 Cr |
| EPS | 4.47 | -0.32 | 2.62 | 10.1 | 16.8 | 15.42 | 10.51 | -8.45 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,236 Cr | ₹1,258 Cr | ₹1,272 Cr | ₹1,315 Cr | ₹1,486 Cr | ₹1,658 Cr | ₹2,145 Cr | ₹2,430 Cr |
| Total Liabilities | ₹561 Cr | ₹597 Cr | ₹592 Cr | ₹546 Cr | ₹581 Cr | ₹630 Cr | ₹1,034 Cr | ₹1,412 Cr |
| Equity | ₹675 Cr | ₹661 Cr | ₹680 Cr | ₹769 Cr | ₹905 Cr | ₹1,028 Cr | ₹1,110 Cr | ₹1,018 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹133 Cr | ₹136 Cr | ₹127 Cr | ₹102 Cr | ₹215 Cr | ₹240 Cr | ₹175 Cr | ₹111 Cr |
| Investing | ₹-136 Cr | ₹-104 Cr | ₹-56 Cr | ₹-67 Cr | ₹-121 Cr | ₹-208 Cr | ₹-434 Cr | ₹-339 Cr |
| Financing | ₹-39 Cr | ₹-16 Cr | ₹-64 Cr | ₹-30 Cr | ₹-44 Cr | ₹23 Cr | ₹280 Cr | ₹241 Cr |
| Free Cash Flow | ₹-7 Cr | ₹39 Cr | ₹68 Cr | ₹25 Cr | ₹90 Cr | ₹33 Cr | ₹-253 Cr | ₹-245 Cr |
Shareholding
Promoter 58.86% Institutions 19.09% Public 22.04%
Efficiency & Working Capital
ROCE0.8%
Interest Coverage-0.1
Dividend Payout—
Debtor Days77 d
Inventory Days92 d
Payable Days46 d
Cash Conversion Cycle124 d
Working Capital Days169 d
Shareholding Details
As of 2026-03-31
Promoter58.9%
FII0.9%
DII18.2%
Institutions19.1%
Public22%
Promoter Pledge0%
No. of Shareholders32,276
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 58.7% | 58.7% | 58.7% | 58.7% | 58.8% | 58.8% | 58.8% | 58.9% | 58.9% | 58.9% | 58.9% | 58.9% |
| FIIs | 1.6% | 1.6% | 1.7% | 1.9% | 1.5% | 1.7% | 1.2% | 1.2% | 1.2% | 1.2% | 1.1% | 0.9% |
| DIIs | 17.9% | 17.8% | 19.6% | 19.4% | 18.7% | 18.2% | 18.9% | 18.8% | 19% | 18.2% | 18.1% | 18.2% |
| Public | 21.8% | 21.9% | 20% | 20% | 21.1% | 21.3% | 21.1% | 21.1% | 20.9% | 21.7% | 21.9% | 22% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 35,431 | 36,588 | 32,600 | 33,201 | 34,511 | 34,416 | 34,676 | 34,497 | 33,129 | 33,319 | 32,659 | 32,276 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Spa Holdings Pvt Ltd | Shareholding of Promoter and Promoter Group | 19.9% | 1.83 Cr |
| Shanteri Investment Pvt Ltd | Shareholding of Promoter and Promoter Group | 17.2% | 1.59 Cr |
| Kare Family Private Trust | Shareholding of Promoter and Promoter Group | 14.2% | 1.31 Cr |
| Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund | Public Shareholding | 4.8% | 44,29,483 |
| Quant Mutual Fund - Quant Small Cap Fund | Public Shareholding | 4.6% | 41,99,230 |
| Dsp Healthcare Fund | Public Shareholding | 4% | 36,95,939 |
| Panandikar Aditi Milind | Shareholding of Promoter and Promoter Group | 3.2% | 29,17,158 |
| Madhura Suresh Kare | Shareholding of Promoter and Promoter Group | 2.7% | 24,79,513 |
| Franklin India Small Cap Fund | Public Shareholding | 2.2% | 20,25,592 |
| Hdfc Value Fund | Public Shareholding | 1.7% | 15,34,403 |
| Kare Suresh Govind | Shareholding of Promoter and Promoter Group | 1.4% | 12,92,941 |
| Mangeshi Investment Private Limited | Public Shareholding | 1.3% | 11,67,300 |
| Suresh Govind Kare Huf (karta- Suresh Govind Kare) | Shareholding of Promoter and Promoter Group | 0.3% | 2,73,500 |
| Sharda Ramnath Kare | Shareholding of Promoter and Promoter Group | 0% | 32,500 |
| Pratima Ajit Vaidya | Shareholding of Promoter and Promoter Group | 0% | 26,550 |
| Pooja Rajendra Pai | Shareholding of Promoter and Promoter Group | 0% | 10,767 |
| Milind S Panandikar | Shareholding of Promoter and Promoter Group | 0% | 7,500 |
| Ramanath Govind Kare | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Megh Milind Panandikar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mahika Milind Panandikar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rohan Anup Ramani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kare Aruna Suresh | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Kare Family Private Trust | 0 | 0% | 2026-03-31 |
| Panandikar Aditi Milind | 0 | 0% | 2026-03-31 |
| Madhura Suresh Kare | 0 | 0% | 2026-03-31 |
| Kare Aruna Suresh | 0 | 0% | 2026-03-31 |
| Kare Suresh Govind | 0 | 0% | 2026-03-31 |
| Suresh Govind Kare Huf (karta- Suresh Govind Kare) | 0 | 0% | 2026-03-31 |
| Spa Holdings Pvt Ltd | 0 | 0% | 2026-03-31 |
| Sharda Ramnath Kare | 0 | 0% | 2026-03-31 |
| Pratima Ajit Vaidya | 0 | 0% | 2026-03-31 |
| Pooja Rajendra Pai | 0 | 0% | 2026-03-31 |
| Milind S Panandikar | 0 | 0% | 2026-03-31 |
| Ramanath Govind Kare | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Suresh G Kare | Chairman & Non Executive Dir. | 2025 |
| Aditi Kare Panandikar | ED / MD / Promoter | 2025 |
| Sundeep V Bambolkar | Joint MD & Executive Director | 2025 |
| Anand Nadkarni | Non-Exec & Non-Independent Dir | 2025 |
| Satish Shenoy | Independent Non Exe. Director | 2025 |
| Ajay Mulgaokar | Independent Non Exe. Director | 2025 |
| Vasudha V Kamat | Independent Non Exe. Director | 2025 |
| Abhijit Y Gore | Independent Non Exe. Director | 2025 |
| RAMANATHAN HARIHARAN | CS / Compliance Officer / Legal Head | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹916 Cr | 61.3% |
| Outside India | ₹579 Cr | 38.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 25 | 18 | 18 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-28 | Board Meetings | — |
| dividend | 2025-09-04 | ₹0.2 (10%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 52 | 464 | 526 |
| 2025 | 0 | 0 | 0 | 0 | 304 | 304 |
| 2025 | 0 | 0 | 0 | 21 | 106 | 126 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Kare Family Private TrustAcquisition · 55,34,874
Aruna Suresh KareDisposal · 55,34,874
Kare Family Private TrustAcquisition · 75,62,181
Aruna Suresh KareAcquisition · 55,34,874
Aruna Suresh KareDisposal · 47,94,714
Suresh Govind KareDisposal · 27,67,467
Substantial Acquisitions (SAST)
26 disclosure(s)
Off Market26/12/2025 · 55,34,874
-26/12/2025 · 55,34,874
NULL25/12/2025 · 55,34,874
Off Market Transfer25/11/2025 · 4,72,90,860
-25/11/2025 · 1,30,97,055
NULL25/11/2025 · 1,30,97,025
Company Information
🌐 www.indoco.com ↗
📍 Indoco House 166 C S T Road, Santacruz (East) Kalina, Mumbai, Maharashtra, 400098
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search